Katharine Peterson Acrivon Therapeutics, Inc. (ACRV) insider trading activity

Shares Held (Direct Ownership) 4.12K

2.35% 3M change

9.11% 12M change

Total Value Held N/A

Katharine Peterson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2025	SELL Payment of exercise price or tax liability	$221 $2.24 p/Share	99 Reduced 2.35%	4,122 Common Stock
Aug 14 2025	SELL Payment of exercise price or tax liability	$137 $1.39 p/Share	99 Reduced 2.29%	4,221 Common Stock
May 14 2025	SELL Payment of exercise price or tax liability	$112 $1.14 p/Share	99 Reduced 2.24%	4,320 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$628 $5.42 p/Share	116 Reduced 2.56%	4,419 Common Stock
Nov 14 2024	SELL Payment of exercise price or tax liability	$784 $7.92 p/Share	99 Reduced 2.14%	4,535 Common Stock
Aug 14 2024	SELL Payment of exercise price or tax liability	$694 $7.02 p/Share	99 Reduced 2.09%	4,634 Common Stock
May 14 2024	SELL Payment of exercise price or tax liability	$827 $8.36 p/Share	99 Reduced 2.05%	4,733 Common Stock

Chief Accounting Officer

Watertown, MA

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Value

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

Operation

Value

Type

Receive news related to Acrivon Therapeutics, Inc.